Axiom Investors LLC Blueprint Medicines Corp Transaction History
Axiom Investors LLC
- $11 Billion
- Q1 2024
A detailed history of Axiom Investors LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Axiom Investors LLC holds 44,270 shares of BPMC stock, worth $4.94 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
44,270
Previous 23,982
84.6%
Holding current value
$4.94 Million
Previous $2.21 Million
89.83%
% of portfolio
0.04%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding BPMC
# of Institutions
313Shares Held
60.6MCall Options Held
634KPut Options Held
691K-
Black Rock Inc. New York, NY6.45MShares$720 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$705 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.25MShares$698 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$466 Million0.07% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.5MShares$279 Million6.2% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.67B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...